
X
High cost of cancer drugs takes centre stage at ASCO
https://pharmaphorum.com/news/high-cost-cancer-drugs-takes-centre-stage-asco/
ASCO serves up shock as Roche’s data disappoints
Data sets AZ up to file Lynparza in new indication
Tesara and Takeda among other companies to publish data.
Immunotherapy combinations will be the focus – but attention is shifting towards these agents proving their overall survival benefits.